Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02750358
Title Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford Connecticut 06102 United States Details
Memorial Sloan Kettering Basking Ridge Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 United States Details
Kings County Hopsital Center Brooklyn New York 11203 United States Details
Coney Island Hospital Brooklyn New York 11235 United States Details
Woodhull Hospital Brooklyn New York United States Details
Memorial Sloan Kettering Commack Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester Harrison New York 10604 United States Details
Queens Hospital Center Jamaica New York 11432 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Nassau Uniondale New York 11553 United States Details
Lehigh Valley Health Network Allentown Pennsylvania 18103 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field